Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia

Lung cancer (LC) is the most common malignancy responsible for 1.8 million of deaths worldwide. Lung and bronchus cancer represents 13% (n = 1217) of all new cancer cases in Georgia. In 2018, in Georgian males lung cancer age-standardized incidence rate was 35.7/per 100 000, less compared to regiona...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ivane Kiladze, Elene Mariamidze, Branislav Jeremic
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Medicine (General) R5-920 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/62c3740fcbf9471db3b249b7ce753afc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:62c3740fcbf9471db3b249b7ce753afc
record_format	dspace
spelling	oai:doaj.org-article:62c3740fcbf9471db3b249b7ce753afc2021-11-03T21:34:24ZReal-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia1178-632910.1177/11786329211055296https://doaj.org/article/62c3740fcbf9471db3b249b7ce753afc2021-11-01T00:00:00Zhttps://doi.org/10.1177/11786329211055296https://doaj.org/toc/1178-6329Lung cancer (LC) is the most common malignancy responsible for 1.8 million of deaths worldwide. Lung and bronchus cancer represents 13% (n = 1217) of all new cancer cases in Georgia. In 2018, in Georgian males lung cancer age-standardized incidence rate was 35.7/per 100 000, less compared to regional countries as Turkey (70.6), Russia (48.2), Ukraine (41.7), and Armenia (58.5), but higher than in neighbor Azerbaijan (25.5). Incidence is higher compared to central and eastern Europe (27.3) and near similar to North America (34.5). Georgia is an Eastern European, middleincome country with 3.7 million residents and one of the highest numbers of active smokers in the European Region. The Georgian health care system is divided into a public and a private sector, with coverage of nearly 100% of the population. There is a national healthcare system as well as private insurance and all patients, irrespective of insurance (private or governmental) can choose the hospital for treatment by themselves all over the country. The Basic Package of the Universal Health Care Program includes the treatment of oncologic patients, specifically surgery, chemotherapy, hormone therapy and radiotherapy and investigations and medications related to these procedures. The program covers all types of laboratory and instrumental investigations related to planned treatment. Georgia lacks an LC screening program for smokers and partially because of this, the majority of patients with lung cancer present at an advanced stage. The National Centre for the Disease Control (NCDC) showed that almost 90% of LC patients in the country present with advanced stages (III-IV) with 60% of patients having stage IV disease at diagnosis . Lung cancer is generally diagnosed at an advanced stage. For non-small cell lung cancer (NSCLC), the proportion with metastatic disease (TNM stage IV) ranged from 46.8% to 61.2% in developed countries. In recent years, there have been several publications addressing specifics of LC worldwide, but none concerning Georgia. In light of the rapidly changing landscape in the diagnosis, staging, and treatment of LC, we thought to define the state of practice in Georgia by convening specialists who treat LC across 13 institutions in our country with the goal to describe differences in access and approaches to LC.Ivane KiladzeElene MariamidzeBranislav JeremicSAGE PublishingarticleMedicine (General)R5-920Public aspects of medicineRA1-1270ENHealth Services Insights, Vol 14 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920 Public aspects of medicine RA1-1270
spellingShingle	Medicine (General) R5-920 Public aspects of medicine RA1-1270 Ivane Kiladze Elene Mariamidze Branislav Jeremic Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia
description	Lung cancer (LC) is the most common malignancy responsible for 1.8 million of deaths worldwide. Lung and bronchus cancer represents 13% (n = 1217) of all new cancer cases in Georgia. In 2018, in Georgian males lung cancer age-standardized incidence rate was 35.7/per 100 000, less compared to regional countries as Turkey (70.6), Russia (48.2), Ukraine (41.7), and Armenia (58.5), but higher than in neighbor Azerbaijan (25.5). Incidence is higher compared to central and eastern Europe (27.3) and near similar to North America (34.5). Georgia is an Eastern European, middleincome country with 3.7 million residents and one of the highest numbers of active smokers in the European Region. The Georgian health care system is divided into a public and a private sector, with coverage of nearly 100% of the population. There is a national healthcare system as well as private insurance and all patients, irrespective of insurance (private or governmental) can choose the hospital for treatment by themselves all over the country. The Basic Package of the Universal Health Care Program includes the treatment of oncologic patients, specifically surgery, chemotherapy, hormone therapy and radiotherapy and investigations and medications related to these procedures. The program covers all types of laboratory and instrumental investigations related to planned treatment. Georgia lacks an LC screening program for smokers and partially because of this, the majority of patients with lung cancer present at an advanced stage. The National Centre for the Disease Control (NCDC) showed that almost 90% of LC patients in the country present with advanced stages (III-IV) with 60% of patients having stage IV disease at diagnosis . Lung cancer is generally diagnosed at an advanced stage. For non-small cell lung cancer (NSCLC), the proportion with metastatic disease (TNM stage IV) ranged from 46.8% to 61.2% in developed countries. In recent years, there have been several publications addressing specifics of LC worldwide, but none concerning Georgia. In light of the rapidly changing landscape in the diagnosis, staging, and treatment of LC, we thought to define the state of practice in Georgia by convening specialists who treat LC across 13 institutions in our country with the goal to describe differences in access and approaches to LC.
format	article
author	Ivane Kiladze Elene Mariamidze Branislav Jeremic
author_facet	Ivane Kiladze Elene Mariamidze Branislav Jeremic
author_sort	Ivane Kiladze
title	Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia
title_short	Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia
title_full	Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia
title_fullStr	Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia
title_full_unstemmed	Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia
title_sort	real-world treatment patterns of lung cancer in a resource-restricted country: the experience of georgia
publisher	SAGE Publishing
publishDate	2021
url	https://doaj.org/article/62c3740fcbf9471db3b249b7ce753afc
work_keys_str_mv	AT ivanekiladze realworldtreatmentpatternsoflungcancerinaresourcerestrictedcountrytheexperienceofgeorgia AT elenemariamidze realworldtreatmentpatternsoflungcancerinaresourcerestrictedcountrytheexperienceofgeorgia AT branislavjeremic realworldtreatmentpatternsoflungcancerinaresourcerestrictedcountrytheexperienceofgeorgia
_version_	1718445399603150848

Real-World Treatment Patterns of Lung Cancer in a Resource-Restricted Country: the Experience of Georgia

Ejemplares similares